Primary |
Chronic Hepatitis C |
39.1% |
Hepatitis C |
37.8% |
Product Used For Unknown Indication |
3.9% |
Hepatic Cirrhosis |
3.4% |
Hypertension |
3.1% |
Chronic Hepatitis B |
1.6% |
Depression |
1.6% |
Hiv Infection |
1.4% |
Prophylaxis |
1.2% |
Hepatitis B |
1.1% |
Diabetes Mellitus |
0.9% |
Insomnia |
0.7% |
Chronic Myeloid Leukaemia |
0.7% |
Malignant Melanoma |
0.7% |
Anxiety |
0.6% |
Anaemia |
0.5% |
Prophylaxis Against Transplant Rejection |
0.5% |
Gastritis |
0.4% |
Hypothyroidism |
0.4% |
Pain |
0.4% |
|
White Blood Cell Count Decreased |
12.1% |
Thrombocytopenia |
11.3% |
Hepatitis C |
9.1% |
Syncope |
8.3% |
Pancytopenia |
7.3% |
Vomiting |
6.2% |
Weight Decreased |
5.6% |
Viral Load Increased |
5.1% |
Sepsis |
4.3% |
Death |
4.0% |
Pyrexia |
4.0% |
Rash |
3.5% |
Leukopenia |
3.2% |
Renal Failure |
3.0% |
Autoimmune Hepatitis |
2.4% |
Deep Vein Thrombosis |
2.2% |
Hepatocellular Carcinoma |
2.2% |
Pneumonia |
2.2% |
Urinary Tract Infection |
2.2% |
Neutropenia |
1.9% |
|
Secondary |
Chronic Hepatitis C |
31.6% |
Hepatic Cirrhosis |
26.6% |
Hepatitis C |
21.0% |
Prophylaxis |
3.3% |
Hypertension |
3.2% |
Product Used For Unknown Indication |
2.1% |
Hiv Infection |
2.0% |
Gastritis |
1.9% |
Hepatitis B |
1.2% |
Thrombocytopenia |
1.2% |
Chronic Hepatitis B |
1.0% |
Insomnia |
1.0% |
Chronic Myeloid Leukaemia |
0.6% |
Immunosuppression |
0.6% |
Pruritus |
0.6% |
Myelofibrosis |
0.5% |
Oropharyngeal Pain |
0.5% |
Anxiety |
0.5% |
Depression |
0.4% |
Influenza Like Illness |
0.4% |
|
White Blood Cell Count Decreased |
25.2% |
Pyrexia |
11.0% |
Thrombocytopenia |
8.0% |
Hepatitis C |
7.4% |
Leukopenia |
6.1% |
Syncope |
4.9% |
Viral Load Increased |
4.9% |
Pancytopenia |
3.7% |
Sepsis |
3.7% |
Weight Decreased |
3.7% |
Vomiting |
3.1% |
Anaemia |
2.5% |
Neutrophil Count Decreased |
2.5% |
Rash |
2.5% |
Renal Failure |
2.5% |
Urinary Tract Infection |
2.5% |
Suicidal Ideation |
1.8% |
Tremor |
1.8% |
Ascites |
1.2% |
Ataxia |
1.2% |
|
Concomitant |
Chronic Hepatitis C |
35.3% |
Hepatitis C |
27.5% |
Hypertension |
9.8% |
Prophylaxis |
9.8% |
Occupational Asthma |
3.9% |
Anaemia Of Chronic Disease |
2.0% |
Anxiety |
2.0% |
Constipation |
2.0% |
Insomnia |
2.0% |
Neck Pain |
2.0% |
Off Label Use |
2.0% |
Pain |
2.0% |
|
Hepatitis C |
21.4% |
Vomiting |
14.3% |
Cytomegalovirus Test |
7.1% |
Haemoglobinuria |
7.1% |
Haemorrhage Intracranial |
7.1% |
No Therapeutic Response |
7.1% |
Pancytopenia |
7.1% |
Rash Generalised |
7.1% |
Tooth Abscess |
7.1% |
Viraemia |
7.1% |
Viral Load Increased |
7.1% |
|
Interacting |
Hepatitis C |
80.0% |
Hiv Infection |
20.0% |
|
|